Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Yasuda, S
Right arrow Articles by Shohtsu, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yasuda, S
Right arrow Articles by Shohtsu, A
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology Pages 387-389


A Small Breast Cancer Detected by PET
Introduction
Case Report
Discussion
References

A Small Breast Cancer Detected by PET

A Small Breast Cancer Detected by PET

Seiei Yasuda1,3, Mitsuhiro Kubota1, Takayuki Tajima1, Tomoo Tajima1, Shinobu Umemura2, Hirofumi Fujii3, Wakoh Takahashi3, Michiru Ide3 and Akira Shohtsu3

1Department of Surgery and 2Department of Pathology, Tokai University School of Medicine, Kanagawa and 3HIMEDIC Imaging Center at Lake Yamanaka, Yamanashi, Japan

A small breast cancer was detected by positron emission tomography (PET) in an asymptomatic individual. Physical examination, mammography and magnetic resonance imaging all failed to identify the tumor. Treatment was partial resection of the breast. Based on the resected specimen, the tumor was 6 mm in diameter. Although previous studies have shown PET to be highly sensitive for the detection of primary breast cancer, detectability of tumors smaller than 1 cm is uncertain. Our case suggests the potential utility of PET for the early detection of primary breast cancer.

Key words: breast cancer - positron emission tomography (PET) - [18F]fluorodeoxyglucose (FDG) - glucose metabolism - early detection

INTRODUCTION

Because of limited spatial resolution, positron emission tomography (PET) using [18F]fluorodeoxyglucose (FDG) is thought to have low sensitivity for detecting lesions smaller than 1 cm in diameter. In breast cancer, for example, a tumor can be clearly depicted with FDG PET, but most such reported lesions have been larger than 1 cm (1). However, we discovered a small breast cancer by PET in an asymptomatic individual. The tumor was 6 mm in diameter. We present the case and discuss the potential utility of PET.

CASE REPORT

An apparently healthy 45-year-old woman underwent a whole-body PET study as a part of our cancer screening program (2). She gave her informed consent beforehand and fasted for 5 h before the study, which was performed using an ECAT EXACT 47 whole-body PET scanner (Siemens/CTI, Knoxville, TN, USA). Forty-seven axial slices were obtained in a field of view of 16.2 cm; the spatial resolution (FWHM) was 6 mm in the transaxial plane and 5.4 mm in the axial plane. Forty-five minutes after administration of 260 MBq of FDG, an emission scan of 7 min from the pelvis to the maxilla was acquired at each bed position. The patient was examined in the supine position. Transmission scans for attenuation correction were not obtained. On the PET images, focal FDG accumulation was easily recognized in the right breast, suggesting a breast carcinoma (Fig. 1).

   a
   b

Figure 1. (a) High FDG uptake is noted in the right breast (arrow) on six consecutive transverse PET images. (b) A small FDG accumulation is again demonstrated (arrow) on four consecutive coronal tomographic images.

Ultrasonography (US) of the breast is a routine examination and is performed by experienced technologists with a 7.5 MHz annular array transducer (Model SSA 250A, Toshiba, Tokyo, Japan). Ultrasonographic screening in this patient immediately prior to the PET study identified no abnormality, whereas US re-examination after the PET study revealed a small lesion (Fig. 2). The tumor was not palpable. The patient was referred to a university hospital for further evaluation and underwent mammography and contrast-enhanced magnetic resonance imaging. Both studies, however, failed to identify the breast lesion. Surgery was decided upon and partial resection of the breast gland was carried out. Lymph node dissection was not performed. The freshly resected tumor was 6 mm in diameter (Fig. 3). On histological sections after fixation and staining, the tumor was 3 mm. Histopathologically, the tumor mass was composed of atypical cells arranged in a tubular or cribriform manner; the nuclei were enlarged and round. No invasion to the surrounding stroma was detected. The tumor was diagnosed as a non-invasive ductal carcinoma (intraductal carcinoma) (Fig. 4).


Figure 2. An ultrasonographic image obtained after the PET study displays a low echoic area measuring 4 mm in diameter.


Figure 3. According to the cut surface of the resected specimen, the tumor is 6 mm in diameter (arrow heads).


Figure 4. A microphotograph demonstrates proliferation of atypical epithelial cells arranged in a tubular pattern. A regular cribriform pattern is occasionally noted and stromal invasion is not evident. Microscopically, the tumor appears to be a non-invasive ductal carcinoma. Hematoxylin-eosin stain, ×300.

Table 1. PET results for the tumors smaller than 1 cm
Study PET results (mm)*
Positive Negative
Crowe et al. (1994) (5) 9 [1]  
Scheidhauer et al. (1996) (6) 4-10 [3]  
Avril et al. (1996) (7)   [sim]10 [5]
Bombardieri et al. (1996) (8) 7-9 [3]  
Palmedo et al. (1997) (9)   8 [1]
Crippa et al. (1998) (10) 4-10 [15]  
Crippa et al. (1998) (11)   5-8 [4]
*Numbers of tumors studied are given in brackets.

DISCUSSION

With PET, high sensitivity (92%), specificity (97%) and accuracy (92%) have been achieved for the diagnosis of primary breast cancer (3). However, most previous studies have involved breast masses larger than 1 cm in diameter (4). Detection of small breast cancer is thought to be limited owing to a partial volume effect and few reports are available with regard to the detectability of primary breast cancers smaller than 1 cm in diameter (Table 1).

Only a few tumors smaller than 1 cm have been reported to be visualized with PET and the lower limit in two reports was 4 mm (6,10). However, the reported measurements were via a pathological section in one study (10) and the measurement methods were not described in the other (6). Surgical specimens contract during fixation and staining; the resulting pathology sections are smaller than the fresh specimens. In our case, the surgical specimen was 6 mm and the pathology specimen was 3 mm in diameter. This case and others suggest that primary breast cancers smaller than 1 cm can be identified by PET. Although this patient had undergone a PET study 9 months earlier, abnormal FDG uptake was not recognized even in retrospective analysis. This indicates a size limitation with PET imaging for detecting small breast cancer.

Currently, the combination of physical examination, mammography and fine-needle aspiration cytology (FNAC) is the standard diagnostic approach (12). However, both physical examination and mammography were negative in our case. Since US screening prior to the PET study failed to detect the small lesion, the tumor would have been missed without PET. Following observation of the high FDG uptake, US re-examination disclosed a small low echoic lesion. However, the lesion was too small to be characterized by US. In such a case, FNAC may be the next best step. The sensitivity and specificity of FNAC are variable according to reports and it is not sufficiently accurate either to rule out the existence of cancer or to ascertain its presence (12). Furthermore, cancer cell spillage cannot always be avoided in the aspiration tract. This may cause problems if partial resection is chosen as a surgical treatment. In our patient, FNAC was deliberately avoided and partial resection was performed. Our case showed that PET may provide information for the characterization of even small breast lesions and may contribute to the management of small breast tumors.

The detectability of breast cancer by PET does not depend solely on tumor size. A study using transplantable tumors showed that the principal sites of FDG uptake are viable cancer cells and that the degree of FDG uptake depends on tumor cellularity (13). In our case, cancer cells were rather densely packed in a small amount of fibrous connective tissue and neither necrosis nor granulation was present. Furthermore, lesions toward the body surface are more clearly depicted on non-attenuation-corrected PET images (14) that were used in the imaging of our case.

Previous studies have shown that PET is sensitive in the diagnosis of primary breast cancer. However, false-positive PET findings may occur in inflammatory lesions and the specificity has not been fully determined in a large number of benign lesions, including fibrocystic diseases and fibroadenomas. Therefore, reported results should be considered preliminary and PET is still not a substitute for tissue diagnosis. In conclusion, our experience and previous reports demonstrate that PET has potential in the diagnosis of small breast cancers even smaller than 1 cm in diameter.

References

1. Adler DD, Wahl RL. New methods for imaging the breast: techniques, findings and potential. Am J Roentgenol 1995;164:19-30.

2. Yasuda S, Shohtsu A. Cancer screening with whole-body [18F]fluorodeoxyglucose positron-emission tomography. Lancet 1997;350:1819. MEDLINE Abstract

3. Conti PS, Lilien DL, Hawley K, Keppler J, Grafton ST, Bading JR. PET and [18F]FDG in oncology: a clinical update. Nucl Med Biol 1996;23:717-35. MEDLINE Abstract

4. Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jerusalem G, et al. Oncological application of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996;23:1641-74. MEDLINE Abstract

5. Crowe JP Jr, Adler LP, Shenk RR, Sunshine J. Positron emission tomography and breast masses: comparison with clinical, mammographic and pathological findings. Ann Surg Oncol 1994;1:132-40. MEDLINE Abstract

6. Scheidhauer K, Scharl A, Pietrzyk U, Wagner R, Göhring U-J, Schomäcker K, et al. Qualitative [18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability. Eur J Nucl Med 1996;23:618-23. MEDLINE Abstract

7. Avril N, Dose J, Jänicke F, Bense S, Ziegler S, Laubenbacher C, et al. Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose. J Clin Oncol 1996;14:1848-57. MEDLINE Abstract

8. Bombardieri E, Crippa F, Maffioli L, Chiti A, Castellani M, Greco M, et al. Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer: can positron emission tomography (PET) with 18F-FDG be considered as the best method? Int J Oncol 1996;8:693-9.

9. Palmedo H, Bender H, Grünwald F, Mallmann P, Zamora P, Krebs D, et al. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours. Eur J Nucl Med 1997;24:1138-45. MEDLINE Abstract

10. Crippa F, Seregni E, Agresti R, Chiesa C, Pascali C, Bogni A, et al. Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation. Eur J Nucl Med 1998;25:1429-34. MEDLINE Abstract

11. Crippa F, Agresti R, Seregni E, Greco M, Pascali C, Bogni A, et al. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer. J Nucl Med 1998;39:4-8. MEDLINE Abstract

12. Donegan WL. Diagnosis. In: Donegan WL, Spratt DJ, editors. Cancer of the Breast, 4th ed. Philadelphia, PA: Saunders 1995;157-205.

13. Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? J Nucl Med 1995;36:1854-61. MEDLINE Abstract

14. Yasuda S, Ide M, Takagi S, Shohtsu A, Mitomi T, Kobayashi S, et al. Cancer detection with whole-body FDG PET images without attenuaion correction. Kaku Igaku (Jpn J Nucl Med) 1996;33:367-73 (in Japanese).


Received March 8, 1999; accepted May 17, 1999
For reprints and all correspondence: Seiei Yasuda, HIMEDIC Imaging Center at Lake Yamanaka, Hirano, Yamanashi, 401-0502, Japan
Abbreviations: PET, positron emission tomography; FDG, [18F]fluorodeoxyglucose; US, ultrasonography; FNAC, fine-needle aspiration cytology


This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals
Comments and feedback: jnl.info{at}oup.co.uk
Last modification: 23 Aug 1999
Copyright© 1999 Foundation for Promotion of Cancer Research.

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
RadiologyHome page
H. Agress Jr and B. Z. Cooper
Detection of Clinically Unexpected Malignant and Premalignant Tumors with Whole-Body FDG PET: Histopathologic Comparison
Radiology, February 1, 2004; 230(2): 417 - 422.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Yasuda, S
Right arrow Articles by Shohtsu, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yasuda, S
Right arrow Articles by Shohtsu, A
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?